"Application of self-made blood""sampling-taking-transfusion""simulation video in management of ;safe blood transfusion" / 中国实用护理杂志

Objective To study the effects of self-made blood sampling-taking-transfusionsimulation video in the management of safe blood transfusion. Methods According to the tracking results, the process of blood transfusion were improved. Then blood sampling-taking-transfusionsimulation video was made that was used in the safe management of blood transfusion and their effects were evaluated. Results The blood transfusion knowledge score and self-efficacy score of nurses were 87.32 ± 7.08, 2.83 ± 0.84, and that of before improvement were 78.38 ± 8.46, 2.52 ± 0.78, and there were statistically significant differences (t=-14.486,-3.274, P<0.01). The qualification rate of blood specimen collection, assessment and check before blood transfusion and nursing record were 97.14% (68/70), 98.57%(69/70), 97.14%(68/70), 98.57%(69/70), and that of before improvement were 51.43%(36/70), 78.57% (55/70), 68.57% (48/70), 82.86% (58/70), the difference was statistically significant (χ2=38.291, 13.831, 20.115, 10.206, P<0.01). The qualified rate of safe blood transfusion increased from 81.43%(57/70) before improvement to 100.00% (70/70) (χ2=14.331, P<0.01). Conclusions Self-made bloodsampling-taking-transfusionsimulation video in the safe management of blood transfusion is effective.

Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam.

Background & objectives: Safe blood and blood products should be offered to all patients in need for blood transfusion. The objectives of the present study were to establish prevalence estimates for hepatitis B and hepatitis C virus infections as a foundation for safe blood transfusion in rural Vietnam, and to check the accuracy of the laboratory analysis used for hepatitis testing of blood donors in Vietnam. Methods: A cross-sectional study was conducted in two rural communities in Quang Tri, Vietnam. A total of 1,200 blood samples collected from potential blood donors were tested by an enzyme immunoassay technique (EIA) for detection of hepatitis surface antigen (HBsAg), antibodies to hepatitis B core antigen (anti-HBc), and antibodies to hepatitis C antigen (anti-HCV). The EIA test outcome was validated by a chemiluminescent micro particle immunoassay technique (CMIA). Results: The prevalence of HBsAg and anti-HBc in the study population was 11.4 per cent (95% CI 9.6 - 13.2) and 51.7 per cent (95% CI 48.8 - 54.5), respectively, the prevalences being higher in males than females. The prevalence of anti-HCV was 0.17 per cent. The test agreement between the EIA and CMIA techniques was high both for HBsAg detection (κ = 0.91; 95% CI: 0.83 - 0.99) and for anti-HBc detection (κ = 0.89; 95% CI 0.81 - 0.97). Compared to CMIA results, the positive and negative predictive values of the EIA tests were found to be 94.9 per cent (95% CI 87.5 - 98.6) and 97.5 per cent (95% CI 86.8 - 99.9) for HBsAg, and 92.4 per cent (95% CI 84.2 - 97.2) and 100 per cent (95% CI 91.2 - 100) for anti-HBc. Interpretation & conclusions: The study shows that hepatitis B virus infection is endemic in rural areas of Vietnam and that almost half of the population is or has been infected. Hepatitis C infection is rare, but false negative test results cannot be ruled out. Also, the results indicate that the EIA performance in blood donor screening in Vietnam may be sub-optimal, missing 2.5 per cent of hepatitis B virus carriers and falsely excluding more than 7 per cent of blood donors. As the prevalence of hepatitis B infection is high, occult hepatitis B infection may represent a threat to safe blood transfusion. Therefore, nucleic acid amplification testing for HBV should be considered for blood donor screening in Vietnam.

La seguridad de las reservas sanguíneas en la República Mexicana durante los años 1999 a 2003 / Safety of the blood supply in Mexico from 1999 to 2003

Introduction. The incidence of the infection by the viruses of the human immunodeficiency (HIV), hepatitis B (HBV) and hepatitis C (HCV) has diminished enormously in developed countries during the last 20 years; nevertheless, in our country we do not know such an incidence and, therefore, the safety of our blood supply. Material and methods. We performed a retrospective analysis at the Centro Nacional de la Transfusión Sanguínea (CNTS) assessing 17,176,298 serologic tests including HIV, HCV and HBV carried on 5,725,432 blood units collected and informed to the CNTS from January 1999 to December 2003 by all the Mexican blood banks. Prevalence, incidence and residual risk of each one of the aforementioned serologic markers were calculated. Results. The five years mean prevalence for HIV, HBV and HCV has remained steady. The residual risk (RR) when hemagglutination test was employed was 1:977 for HCV; 1:1,564 for HBV and 1:1,262 for HIV. Whereas the RR when ELISA was performed decreased to 1:2,781 for HCV; 1:3,185 for HBV and 1:9,969 for HIV. If nucleic acid amplification test were employed, RR would be 1:8,170 for HBV; 1:9,915 for HCV and 1:19,939 for HIV. Conclusions. The theoretical risk for transfusion-transmitted diseases in our country is still worrisome.

Introducción. La transmisión del virus de la inmunodeficiencia humana (VIH), de la hepatitis C (VHC) y de la hepatitis B (VHB) por transfusión sanguínea ha disminuido de manera significativa en los países industrializados durante los últimos 20 años; sin embargo, en nuestro país aún no conocemos dicha incidencia y consecuentemente la seguridad de nuestras reservas sanguíneas. Material y métodos. Se realizó un estudio retrospectivo en el Centro Nacional de la Transfusión Sanguínea (CNTS) analizando 17,176,298 pruebas serológicas incluyendo VIH, VHC y VHB realizadas a 5,725,432 unidades de sangre captadas e informadas al CNTS de enero de 1999 a diciembre de 2003 por todos los bancos de la República Mexicana. Se calcularon la prevalencia, la incidencia y el riesgo residual para cada uno de los marcadores serológicos mencionados. Resultados. La prevalencia en los cinco años para el VIH, VHB y VHC se ha mantenido estable entre los donantes. El riesgo residual encontrado con la prueba de hemaglutinación fue de 1:977 para el VHC; de 1:1,564 para el VHB y de 1:1,262 para el VIH. Con la prueba de ELISA el riesgo descendió a 1:2,781 para el VHC; 1:3,185 para el VHB y 1:9,969 para el VIH. Si se empleara la prueba de amplificación de ácidos nucleicos, el riesgo disminuiría a 1:8,170 para el VHB; 1:9,915 para el VHC y a 1:19,939 para el VIH. Conclusiones. El riesgo de transmitir infecciones por transfusión sanguínea en nuestro país es todavía preocupante.

Analysis of the relationship between blood donor testing results and crowd structure / 中国输血杂志

Objective To form the basis of establishing a strategy for safe blood donor recruitment and to identify and subdivide the structures of donors.Methods Demographic data of blood donors, and blood testing results of HBsAg, anti-HCV, anti-HIV, and syphilis, from Nov. 2004 to Jun. 2005, were collected and analyzed.Results Among the 45270 voluntary blood donors, the total positive test rate were 3.11%, which was related to age, level of education and occupation of blood donors. About 76.7% of donors were young people, aged from 18 to 30. As the age increased, female donors were less than male ones. Among all the donors, 81.6% received higher education, which had lower positive test rate than those with lower level of education. Among the 45270 donors, farmers had the highest positive test rate; workers and service people came the second; students and medical staff had the lowest. As to donors with incomplete record, the positive test rate was higher than those with complete record.Conclusion During blood donor recruitment, quality control is important. People younger than 30, with student or higher education background, are relatively safe to recruit.